Tianjin Central Pharmaceutical Co., Ltd.
FDA import alert and refusal historyTianjin, ChinaFEI 3003780972
As of October 26, 2026, Tianjin Central Pharmaceutical Co., Ltd. has no FDA import alert listing or import refusal in SupplierRadar's records; its most recent FDA inspection, on December 17, 2021, was classified VAI (Voluntary Action Indicated).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- Classified VAI (Voluntary Action Indicated)
Every FDA record for Tianjin Central Pharmaceutical Co., Ltd.
2 records, newest first. Each line links to the FDA page it came from.
Questions about Tianjin Central Pharmaceutical Co., Ltd.
- Is Tianjin Central Pharmaceutical Co., Ltd. on an FDA import alert?
- No listing for Tianjin Central Pharmaceutical Co., Ltd. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the China page.
- Has FDA refused shipments from Tianjin Central Pharmaceutical Co., Ltd.?
- No FDA import refusals for Tianjin Central Pharmaceutical Co., Ltd. appear in FDA's refusal data since October 2016, as of October 26, 2026.
- When was Tianjin Central Pharmaceutical Co., Ltd. last inspected by FDA?
- FDA's most recent inspection of Tianjin Central Pharmaceutical Co., Ltd. with a final classification is dated December 17, 2021 and was classified VAI (Voluntary Action Indicated).
- What is Tianjin Central Pharmaceutical Co., Ltd.'s FEI number?
- Tianjin Central Pharmaceutical Co., Ltd.'s FDA Establishment Identifier (FEI) is 3003780972.
Buying from Tianjin Central Pharmaceutical Co., Ltd.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.